603229.SHG Zhejiang Ausun Pharmaceutical Co Ltd

Healthcare Biotechnology Shanghai Stock Exchange
7.28 CNY
Close of Nov 5, 2026
6.83 10.81
Market cap
CNY 6.04B
P/E
-
P/B
2.55x
ROE
4.2%
Dividend yield
1.50%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603229.SHG undervalued?

Graham number

The Graham number of Zhejiang Ausun Pharmaceutical Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Zhejiang Ausun Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Zhejiang Ausun Pharmaceutical Co Ltd yet.

Zhejiang Ausun Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Zhejiang Ausun Pharmaceutical Co Ltd

Zhejiang Ausun Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical formulations, specialty active pharmaceutical ingredients (APIs), and pharmaceutical intermediates in China and internationally. The company offers products for liver diseases, respiratory system diseases, cardiovascular and cerebrovascular diseases, high-end fluorine products, prostaglandins, antibacterial agents, gout, anti-t…

Full company profile